Remarks By Rear Admiral R. Timothy Ziemer, President’s Malaria Initiative Coordinator
July 23rd, 2010 | Posted by Meghan MurphyOn June 17, Admiral Ziemer spoke at the Lower Mekong Initiative Infectious Disease Conference in Vietnam to discuss the successes and challenges of implementing the International Health Regulations in the Lower Mekong Initiative countries and identify gaps that could be addressed through regional health collaboration. He outlined the Obama Administration’s four main development goals:
- Commitment to honoring the Millennium Development Goals (MDGs)
- Ensure country ownership and growth through trade, cost-effective and long-term investments, and diplomacy
- Use science and technology to develop and deliver transformative tools and innovations
- Ensure that the U.S. government is planning and implementing foreign assistance in the most efficient way
Admiral Ziemer cited significant progress towards meeting the MDGs in the Mekong region, saying that we should recognize, celebrate and support these achievements. However, there are still gaps, and “the road ahead will likely be more difficult than the road already traveled,” he asserted. “For this reason, we will be even more determined as we strive to meet the MDGs in five years.”
The U.S. Government has prioritized global health and food security as the two focal points of development efforts. Building upon President Bush’s PEPFAR and Malaria initiatives, President Obama has launched a $63 billion 5-year initiative to focus attention on broader global health challenges that adopts a more integrated approach to fighting diseases, improving health, and strengthening health systems. One of the main goals of this Administration’s Global Health Initiative is improving the sustainability of health programs through better integration and partnerships.
There has been substantial progress in malaria control in the Mekong region under this initiative, particularly in Vietnam where the number of malaria cases has declined from about 190,000 in 1991 to less than 15,000 by 2008. However, the region is beginning to experience parasite resistance to artemisinin, the most effective anti-malarial compound. First detected in western Cambodia in 2007, there are now indications of artemisinin resistance in southern Burma and in southern Vietnam near the Vietnam-Cambodia border. “Malaria and drug resistance is a regional issue and we’re taking a regional approach,” explained Admiral Ziemer. “Managed out of our regional office in Bangkok, we work closely with WHO and the National Programs to coordinate an effective response.”
USG funding through the regional office has been over $24 million since 2006, which represents a tripling of funding since 2000. U.S. investments for malaria in the region focus on strategic capacity and information, particularly on drug resistance, drug quality and improving the efficiencies of national program implementation. A key part of the regional malaria strategy is eliminating the fake and substandard medicines that contribute to the development of resistance and to malaria mortality. As Admiral Ziemer states, “trafficking in fake drugs is murder.” Addressing this issue will require a higher focus on accountability and efficiency in malaria systems at the community health level.





